Darin Lippoldt sold $699K of Neurocrine Biosciences (NBIX)

Executed Dec 8 2025, disclosed Dec 10 2025, 2 days later.

Value, as filed

$699K

4,376 sh × $159.65

Executed

Dec 8 2025

the trade date, as filed

Disclosed

Dec 10 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DL Darin Lippoldt Chief Legal Officer profile →

Darin Lippoldt (Chief Legal Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (10,000 sh × $179.60, as filed), executed Jul 9.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Darin Lippoldt in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $1.8M
10,000 sh × $179.60
Exec Jul 9
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. $1.7M
9,800 sh across 2 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $255K
2,184 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $108K
911 sh × $118.25
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $191K
1,250 sh × $152.91
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET